JMJD1C Antibody

Code CSB-PA624030HA01HU
Size US$166
Order now
Image
  • Immunohistochemistry of paraffin-embedded human liver tissue using CSB-PA624030HA01HU at dilution of 1:100

  • Immunohistochemistry of paraffin-embedded human melanoma using CSB-PA624030HA01HU at dilution of 1:100

Promotion Free Antibody trial simple
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) JMJD1C Polyclonal antibody
Uniprot No.
Target Names
JMJD1C
Alternative Names
JHD2C_HUMAN antibody; Jmjd1c antibody; Jumonji domain containing 1C antibody; Jumonji domain-containing protein 1C antibody; Probable JmjC domain-containing histone demethylation protein 2C antibody; Thryoid receptor interacting protein antibody; Thyroid receptor-interacting protein 8 antibody; TR-interacting protein 8 antibody; TRIP-8 antibody; TRIP8 antibody
Raised in
Rabbit
Species Reactivity
Human
Immunogen
Recombinant Human Probable JmjC domain-containing histone demethylation protein 2C protein (539-648AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated

The JMJD1C Antibody (Product code: CSB-PA624030HA01HU) is Non-conjugated. For JMJD1C Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA624030HB01HU JMJD1C Antibody, HRP conjugated ELISA
FITC CSB-PA624030HC01HU JMJD1C Antibody, FITC conjugated
Biotin CSB-PA624030HD01HU JMJD1C Antibody, Biotin conjugated ELISA
Clonality
Polyclonal
Isotype
IgG
Purification Method
>95%, Protein G purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Form
Liquid
Tested Applications
ELISA, IHC
Recommended Dilution
Application Recommended Dilution
IHC 1:20-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Usage
For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Probable histone demethylase that specifically demethylates 'Lys-9' of histone H3, thereby playing a central role in histone code. Demethylation of Lys residue generates formaldehyde and succinate. May be involved in hormone-dependent transcriptional activation, by participating in recruitment to androgen-receptor target genes.
Gene References into Functions
  1. Study provides evidence that SNPs of JMJD1C and KCNQ1 are prospectively associated with the risk of type 2 diabetes (T2D) in Korean population. Additionally, CDKAL1 may not be associated with T2D onset over the age of 40. PMID: 28406950
  2. JMJD1C is one of the target genes of hsa-miR-590- 3p. PMID: 27064872
  3. Our findings indicate that mutations in JMJD1C contribute to the development of Rett syndrome and intellectual disability. PMID: 26181491
  4. genetic variants in the androgen-related genes CYP17A1 and JMJD1C might be associated with risk of Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC). PMID: 26414697
  5. Histone modifier genes (JMJD1C, RREB1, MINA, KDM7A) alter conotruncal heart phenotypes in 22q11.2 deletion syndrome. PMID: 26608785
  6. JMJD1C is directly recruited by RUNX1-RUNX1T1 to its target genes and regulates their expression by maintaining low H3K9 dimethyl (H3K9me2) levels PMID: 26494788
  7. Depletion of JMJD1C impairs expansion and colony formation of leukemic cell lines, with the strongest effect observed in the MLL-rearranged ALL cell line SEM. PMID: 24501218
  8. JMJD1C represses neural differentiation of hESCs at least partially by epigenetically sustaining miR-302 expression PMID: 24318875
  9. JMJD1C regulates the RAP80-BRCA1 branch of this DNA-damage response (DDR) pathway. PMID: 24240613
  10. No evidence for JMJD1C histone demethylase activity towards H3K9. PMID: 23593242
  11. Observational study of gene-disease association. (HuGE Navigator) PMID: 20648472
  12. Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator) PMID: 20379614
  13. Observational study and genome-wide association study of gene-disease association. (HuGE Navigator) PMID: 20526338
  14. TRIP8 gene codes for a protein predicted to be a transcriptional regulator associated with nuclear thyroid hormone receptors. Positional candidate gene for autism. PMID: 17290275
  15. the discovery of a new Receptors, Androgen coactivator which belongs to the JmjC containing enzyme family as a novel variant of JMJD1C PMID: 17353003
  16. Human JMJD1C variant 2 with TRI8H1, TRI8H2, and JmjC domains showed 85.7% total-amino-acid identity with mouse Jmjd1c. PMID: 17549425
  17. Observational study and genome-wide association study of gene-disease association. (HuGE Navigator) PMID: 19936222
  18. Observational study of gene-disease association. (HuGE Navigator) PMID: 16385451
  19. Observational study, meta-analysis, and genome-wide association study of gene-disease association. (HuGE Navigator) PMID: 18940312

Show More

Hide All

Subcellular Location
Nucleus.
Protein Families
JHDM2 histone demethylase family
Database Links

HGNC: 12313

OMIM: 604503

KEGG: hsa:221037

STRING: 9606.ENSP00000382204

UniGene: Hs.413416

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2025 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*